Lombardi; Paolo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lombardi; Paolo.The latest application filed is for "method to extend mes functionalities in a message routing system".

Company Profile

1.13.6

Lombardi; Paolo - Castelnouvo di Garfagnana IT
Lombardi; Paolo - Cesate IT
Lombardi; Paolo - Milan IT
Lombardi; Paolo - Rome IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method to extend MES functionalities in a message routing system Grant 10,353,381 - Lombardi , et al. July 16, 2	2019-07-16
Method To Extend Mes Functionalities In A Message Routing System App 20180059654 - LOMBARDI; PAOLO ; et al.	2018-03-01
Benzoquinolizinium salt derivatives as anticancer agents Grant 8,188,109 - Lombardi , et al. May 29, 2	2012-05-29
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds App 20110130581 - Lombardi; Paolo ; et al.	2011-06-02
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds Grant 7,901,904 - Lombardi , et al. March 8, 2	2011-03-08
Benzoquinolizinium salt derivatives as anticancer agents App 20110015222 - Lombardi; Paolo ; et al.	2011-01-20
Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds App 20100099141 - Lombardi; Paolo ; et al.	2010-04-22
Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate Grant 7,449,547 - Lombardi November 11, 2	2008-11-11
Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate App 20070060523 - Lombardi; Paolo	2007-03-15
Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis App 20060069033 - Lombardi; Paolo	2006-03-30
Distamycin a derivatives as anti-malarial agents Grant 5,670,534 - Animati , et al. September 23, 1	1997-09-23
Tachyquinine antagonists, their preparation and use in pharmaceutical formulations Grant 5,641,802 - Arcamone , et al. June 24, 1	1997-06-24
Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical compositions which contain them Grant 5,472,976 - Animati , et al. December 5, 1	1995-12-05
Total synthesis of erbstatin analogs Grant 5,130,472 - Buzzetti , et al. July 14, 1	1992-07-14
6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation Grant 4,824,830 - Buzzetti , et al. April 25, 1	1989-04-25
4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation Grant 4,822,528 - Colombo , et al. April 18, 1	1989-04-18
Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors Grant 4,797,411 - Crugnola , et al. January 10, 1	1989-01-10
Cycloalkyl-substituted 4-aminophenyl derivatives and process for their preparation Grant 4,769,483 - Lombardi , et al. September 6, 1	1988-09-06
System for the suppression by matching techniques of unwanted echoes in impulse coherent radars Grant 4,217,584 - Lombardi , et al. August 12, 1	1980-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.